Paclitaxel

Basic Information


CAS ID: 33069-62-4
Molecular Formula: C47H51NO14
Molecular Weight: 853.9 g/mol
Monoisotopic Mass: 853.331 g/mol
Class: Small Molecule
Natural Product: Yes
Other Names: BMS-181339-01 | PACITAXEL | PACLITAXEL | PAXENE | ABRAXANE | TAXOL | TAXOL 100
Analysis: Drug repositioning mechanism analysis

O O O HO O O O O O OH O O OH NH O


Compound Structure and Identifier


InChI: InChI=1S/C47H51NO14/c1-25-31(60-43(56)36(52)35(28-16-10-7-11-17-28)48-41(54)29-18-12-8-13-19-29)23-47(57)40(61-42(55)30-20-14-9-15-21-30)38-45(6,32(51)22-33-46(38,24-58-33)62-27(3)50)39(53)37(59-26(2)49)34(25)44(47,4)5/h7-21,31-33,35-38,40,51-52,57H,22-24H2,1-6H3,(H,48,54)/t31-,32-,33+,35-,36+,37+,38-,40-,45+,46-,47+/m0/s1 See All
InChI Key: RCINICONZNJXQF-MZXODVADSA-N
Smiles: CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(=O)C)[C@H]2[C@H](OC(=O)c4ccccc4)[C@]5(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c6ccccc6)c7ccccc7)C(=C1C5(C)C)C See All
Molfile: Download


Related Target



Related Fibrosis Property


Reference Record 1

PubMed ID 22579993 Target ID
Uniprot ID Name
Model vitro Fibrosis Disease Eye fibrosis
Process I
Process II fibroblasts proliferation
Process III
Mechanism

Trial Record 1

ClinicalTrial ID NCT03095001 Disease Peritoneal fibrosis
Phase Phase 2 Status Recruiting
First Received March 29, 2017 Last Verified April 13, 2017
Sponsor Chinese PLA General Hospital

Related Link


PubChem: 36314
ChEMBL: CHEMBL428647